心血管系统中衰老的机制:挑战和机遇
Xiaoying Zhao1, Xinyue Yang1, Yumeng Lin2
1Department of Gerontology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.
Frontiers in immunology
|November 21, 2025
概括
老龄化对老年人的心血管疾病 (CVD) 有重大影响. 本综述探讨了衰老机制如何影响心脏.
科学领域:
- 老年学是一门学科.
- 心脏病学 心脏病学
- 分子生物学分子生物学
背景情况:
- 心血管疾病 (CVD) 是人口老龄化的主要健康问题.
- 全球人口老龄化,心血管疾病管理的重要性日益增加.
- 目前对老年人心血管疾病的医疗管理存在局限性.
研究的目的:
- 审查衰老的机制及其对心血管系统的具体影响.
- 探索衰老在心脏微环境中的作用.
- 为了突出与年龄有关的心脏细胞和分子结构的变化.
主要方法:
- 关于衰老机制的文献综述.
- 对心血管衰老研究的分析.
- 探索因衰老而引起的心脏微环境变化的研究.
主要成果:
- 衰老涉及复杂的机制,有助于心血管疾病的发展和进展.
- 随着年龄的增长,心脏的细胞和分子格局发生了特定的变化.
- 心脏的微环境在衰老过程中发生了显著的变化.
结论:
- 了解衰老机制对于解决老年人心血管疾病至关重要.
- 针对与年龄有关的心脏变化可能会提供新的治疗策略.
- 进一步研究心脏微环境在衰老中的作用是有必要的.
相关概念视频
Aging
573
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
573
The Effect of Aging on Tissues
3.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.1K
Pathophysiology of Heart Failure
2.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Coronary Artery Disease I: Introduction
857
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
857
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
186
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
186


